Vital Therapies (VTL) Tops Q3 EPS by 7c

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.51), $0.07 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c